Skip to main content
. Author manuscript; available in PMC: 2014 Aug 6.
Published in final edited form as: Lancet. 2010 Jun 30;376(9739):419–430. doi: 10.1016/S0140-6736(10)60576-4

Figure A5.

Figure A5

Kaplan-Meier curves for microvascular outcome Neph-4 (doubling of serum creatinine or more than 20 mL/min/1.73m2 decrease in estimated GFR) by glycemia arm. Panel A: data until transition of intensive glycemia arm to standard therapy. Panel B: all data through end of study. Hazard ratios adjusted for baseline history of clinical cardiovascular disease and second trial treatment arm assignment.